MCCP
BNR

Mission Creek Capital Partners’s Burning Rock Biotech BNR Stock Holding History

Mission Creek Capital Partners’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-972
Closed -$225K – 231
2020
Q4 		$225K Buy
+972
New +$261K 0.07% 195

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mission Creek Capital Partners's BNR Position: Q1 2021 in Review

Mission Creek Capital Partners sold out of Burning Rock Biotech (BNR) in Q1 2021, closing a stake of 972 shares — an estimated $225K sold.

Mission Creek Capital Partners first reported a position in BNR in Q4 2020 and held it in 1 quarter. The position peaked at $225K in Q4 2020. 54 funds tracked by Wall St. Rank hold BNR as of Q1 2021.

  • Mission Creek Capital Partners reported no remaining Burning Rock Biotech position as of Q1 2021 after selling out during the quarter.
  • Mission Creek Capital Partners sold 972 Burning Rock Biotech shares in Q1 2021, an estimated $225K.
  • Mission Creek Capital Partners first reported a position in Burning Rock Biotech in Q4 2020 and held it in 1 quarter.
  • Mission Creek Capital Partners's Burning Rock Biotech position peaked at $225K in Q4 2020.
  • 54 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2021.

Based on Mission Creek Capital Partners's 13F filing for Q1 2021, filed 14 May 2021.